Answer
Ramucirumab has a mean elimination half-life of 14 days (coefficient of variation 20%), based on population pharmacokinetic analysis.
Sources for this answer
- Cyramza 10 mg/ml concentrate for solution for infusionEli Lilly and Company Limited · emc · SmPC §5.2 Pharmacokinetic properties · Version 18Document updated
Sources checked